Biotech demand rebound
搜索文档
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
Benzinga· 2025-10-24 00:00
Medpace Holdings Inc. (NASDAQ:MEDP) is trading higher on Thursday after the company released third-quarter earnings.The clinical contract research organization reported earnings of $3.86, beating the consensus of $3.52. Sales reached $659.9 million, surpassing the consensus of $640.99 million.Sales increased 23.7% year over year. On a constant currency basis, revenue jumped 23.4%.Backlog as of September 30, 2025, increased 2.5% to around $3 billion. Net new business awards were $789.6 million, representing ...